Hikma Pharmaceuticals USA Inc. secured the approval of a new generic version of LEUCOVORIN CALCIUM, an essential drug indicated for rescue following methotrexate toxicities, potentially expanding its portfolio within the high-volume oncology and inflammation therapeutics market.